We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

Anti-ACTIVE® MAPK, JNK and p38 Polyclonal Antibodies and Anti-ACTIVE® Qualified...

Anti-ACTIVE® MAPK, JNK and p38 Polyclonal Antibodies and Anti-ACTIVE® Qualified Secondary Antibody Conjugate Technical Bulletin

Literature # TB262

Promega has developed polyclonal antibodies (pAb) to three members of the Mitogen-Activated Protein Kinase (MAPK) superfamily of enzymes. These enzymes, which play important roles in signal transduction in eukaryotic cells, are MAPK, p38 and JNK. These kinases have interconnected roles in a cascade of signal transduction reactions. The Anti-ACTIVE® pAbs are specific for the dually phosphorylated active forms of MAPK, p38 and JNK and provide tools to measure more accurately activation of these enzymes.

Printed in USA. Revised 1/12.


PDF Icon Complete Protocol PDF (4534kb)

PDF Icon Quick Protocol PDF (91kb)

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.